T2DM and Obesity Additively Increase Platelet Hyperreactivity and CV Risk: Study
A new study published in the journal of Thrombosis Research found that the combined presence of type 2 diabetes mellitus (T2DM) and obesity exerts a significant additive effect on platelet hyperreactivity and in vivo platelet activation, when compared to either condition alone.
In metabolically unhealthy obese (MUO) individuals, elevated levels of von Willebrand factor (VWF) and resistin appear to play a pathogenic role in enhancing platelet responsiveness to stimuli. This amplified platelet activation may contribute to an elevated cardiovascular risk in patients with both T2DM and obesity.
Excessive platelet activation can promote dangerous clot formation inside arteries leading to cardiovascular events. While previous research has linked both obesity and type 2 diabetes independently to increased platelet activity, the combined effect of these conditions has remained unclear.
Thus, this study evaluated platelet function and markers of platelet activation in 4 groups of participants from obese individuals without diabetes, normal-weight patients with type 2 diabetes, obese patients with type 2 diabetes, to healthy normal-weight volunteers. Each group was matched for age and sex to ensure reliable comparisons.
The analysis focused on several indicators of platelet behavior from thrombus formation, responsiveness to clotting stimuli, oxidative stress within platelets, to the ability of the body to regulate platelet activity through nitric oxide production. Also, this study measured circulating biological factors associated with inflammation and vascular function.
Both obese participants without diabetes and normal-weight participants with diabetes already demonstrated significant abnormalities when compared to healthy controls.
These individuals had increased platelet clot formation, stronger responses to platelet-activating substances, and higher levels of biochemical markers which indicated ongoing platelet activation in the body. Platelets from these participants produced more reactive oxygen species and showed reduced nitric oxide activity, both of which promote clotting.
The participants who were both obese and diabetic showed substantially greater platelet activation across nearly all measurements, indicating that the two metabolic conditions interact in a way that amplifies clotting risk beyond the effect of either condition alone.
The study also identified elevated levels of von Willebrand factor activity and the inflammatory hormone resistin in obese diabetic participants. These molecules are believed to influence platelet behavior and blood vessel function, which suggests they may play a role in driving the increased platelet reactivity seen in this group. Overall, these findings highlight a potential biological explanation for the especially high cardiovascular risk observed in patients with both obesity and type 2 diabetes.
Source:
Guglielmini, G., Falcinelli, E., De Fano, M., Mezzasoma, A. M., Bury, L., Perriello, G., Minuz, P., Fanelli, C. G., & Gresele, P. (2026). Obesity and type 2 diabetes mellitus add up to induce platelet hyperreactivity and platelet activation. Thrombosis Research, 109626, 109626. https://doi.org/10.1016/j.thromres.2026.109626
